Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$3.71B |
| 2 |
Microsoft
MSFT
|
+$3.52B |
| 3 |
Amazon
AMZN
|
+$2.04B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$1.87B |
| 5 |
Eli Lilly
LLY
|
+$1.31B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.8B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.78B |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$703M |
| 4 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$611M |
| 5 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$573M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.3% |
| 2 | Healthcare | 12.11% |
| 3 | Financials | 10.63% |
| 4 | Consumer Discretionary | 8.09% |
| 5 | Industrials | 6.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IPHA
5501
Innate Pharma
IPHA
$205M
| $184K | ﹤0.01% |
49,367
-7,485
| -13% | -$17.1K |
|
|
TERN
5502
DELISTED
Terns Pharmaceuticals
TERN
| $184K | ﹤0.01% |
18,058
+10,815
| +149% | +$72K |
|
5503
United States 12 Month Oil Fund,
USL
$45M
| $184K | ﹤0.01% |
5,176
-272
| -5% | -$9.54K |
|
5504
NLI Holdings
NL
$317M
| $183K | ﹤0.01% |
26,905
-3,041
| -10% | -$22.7K |
|
|
RBT
5505
DELISTED
Rubicon Technologies, Inc.
RBT
| $183K | ﹤0.01% |
+12,828
| New | +$203K |
|
|
ATHE
5506
Alterity Therapeutics
ATHE
$84.8M
| $183K | ﹤0.01% |
52,436
-2,260
| -4% | -$8.64K |
|
|
AXDX
5507
DELISTED
Accelerate Diagnostics
AXDX
| $182K | ﹤0.01% |
25,749
+22,065
| +599% | +$241K |
|
5508
Legacy Housing
LEGH
$682M
| $181K | ﹤0.01% |
9,549
-827
| -8% | -$14.5K |
|
|
AUTL
5509
Autolus Therapeutics
AUTL
$567M
| $181K | ﹤0.01% |
95,262
+51,312
| +117% | +$130K |
|
|
MBCN
5510
DELISTED
Middlefield Banc Corp
MBCN
| $181K | ﹤0.01% |
6,597
+4,035
| +157% | +$115K |
|
5511
John Marshall Bancorp
JMSB
$337M
| $180K | ﹤0.01% |
6,252
+826
| +15% | +$23K |
|
5512
Seanergy Maritime Holdings
SHIP
$355M
| $180K | ﹤0.01% |
36,270
-19,705
| -35% | -$98.4K |
|
5513
CPI Card Group
PMTS
$337M
| $179K | ﹤0.01% |
4,961
+3,154
| +175% | +$76.8K |
|
|
YJ
5514
Yunji
YJ
$11M
| $179K | ﹤0.01% |
5,471
| – | – |
|
|
HRT
5515
DELISTED
HireRight Holdings Corporation
HRT
| $179K | ﹤0.01% |
15,062
-10,380
| -41% | -$129K |
|
5516
Hycroft Mining Holding Corp
HYMC
$2.51B
| $179K | ﹤0.01% |
33,549
+19,519
| +139% | +$125K |
|
5517
ProShares UltraShort Euro
EUO
$33.2M
| $178K | ﹤0.01% |
6,056
-1,017
| -14% | -$32.8K |
|
5518
WisdomTree Yield Enhanced US Short-Term Aggregate Bond Fund
SHAG
$47.3M
| $178K | ﹤0.01% |
3,813
-151
| -4% | -$7.01K |
|
5519
First Guaranty Bancshares
FGBI
$148M
| $178K | ﹤0.01% |
7,582
-328
| -4% | -$7.6K |
|
|
OMGA
5520
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $177K | ﹤0.01% |
31,060
+13,118
| +73% | +$73.6K |
|
5521
Duos Technologies
DUOT
$288M
| $177K | ﹤0.01% |
88,304
-3,400
| -4% | -$10.1K |
|
|
BCOW
5522
DELISTED
1895 Bancorp of Wisconsin
BCOW
| $176K | ﹤0.01% |
17,607
-1,801
| -9% | -$18.3K |
|
5523
ENDRA Life Sciences
NDRA
$5.8M
| $176K | ﹤0.01% |
25
| – | – |
|
5524
Bioceres Crop Solutions
BIOX
$21.9M
| $174K | ﹤0.01% |
14,483
-1,072
| -7% | -$13.9K |
|
5525
BioVie
BIVI
$8.22M
| $174K | ﹤0.01% |
223
+202
| +962% | +$109K |
|
Similar funds
Morgan Stanley's Q4 2022 Portfolio in Review
As of Q4 2022, Morgan Stanley held 8,205 positions worth $880B, up 20% from $734B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Morgan Stanley deployed $97B of net new capital in Q4 2022, opening 199 new positions and adding to 3,814 existing holdings. Its largest new stake was Rentokil: 2,829,958 shares worth $87.2M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.8B trimmed.
- Morgan Stanley's largest Q4 2022 buy was Rentokil: 2,829,958 shares worth $87.2M.
- Morgan Stanley added most to Apple in Q4 2022, an estimated $3.71B increase.
- Morgan Stanley's biggest Q4 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.8B.
- Morgan Stanley fully exited Twitter, Inc. in Q4 2022, selling an estimated $348M.
- Morgan Stanley's ten largest holdings make up 14% of its $880B portfolio in Q4 2022.
- Morgan Stanley opened 199 new positions and closed 311 in Q4 2022.
- Morgan Stanley's portfolio value rose 20% quarter-over-quarter to $880B.
Based on Morgan Stanley's 13F filing for Q4 2022, filed 14 Feb 2023.